Related Experiment Videos
Factors important in arterial narrowing
S M Schwartz1, M A Reidy, D de Blois
1Department of Pathology, University of Washington School of Medicine, Seattle 98195-7335, USA.
Insights
Vascular narrowing involves cell death and coagulation, not just plaque buildup. Inhibiting coagulation prevents narrowing and may even dilate vessels, suggesting wound healing pathways drive vascular remodeling.
Area of Science:
- Cardiovascular Biology
- Cellular Mechanisms of Disease
- Vascular Physiology
Background:
- Hypertension-associated vascular narrowing has conflicting hypotheses, including structural changes, vasoconstriction, and volume expansion.
- Cellular biology of injured arteries, particularly in atherosclerosis, is complex, with intimal mass poorly correlating to lumen caliber loss.
- Microvessel remodeling analogies do not fully explain the mechanisms of vascular narrowing.
Purpose of the Study:
- To investigate the roles of cell death and intramural coagulation in pathological vascular remodeling.
- To explore classical wound contracture mechanisms as potential drivers of vascular remodeling in response to injury.
Main Methods:
- Focus on cell death and intramural coagulation as key factors in vascular narrowing.
- In vitro studies examining fibrin-mediated smooth muscle cell contraction.
- In vivo experiments involving inhibition of coagulation following vascular reinjury.
Main Results:
- Cell death and tissue factor likely promote coagulation, leading to fibrin formation in previously injured vessels after reinjury.
- In vitro, fibrin induces smooth muscle gel contraction via an unidentified beta 1 integrin.
- In vivo, coagulation inhibition prevents vascular narrowing post-reinjury and can promote vessel dilation.
Conclusions:
- Pathological vascular remodeling may be driven by injury responses analogous to classical wound contracture mechanisms.
- Cell death and intramural coagulation are critical components of vascular narrowing in response to injury.
- Targeting coagulation pathways offers a potential therapeutic strategy for preventing or reversing vascular narrowing.
Background:
Vascular narrowing in hypertension presents conflicting hypotheses about structural narrowing, vasconstriction, volume expansion, contractile function and other issues more obvious to the physiologist than the cell biologist. Even the cell biology in the injured large arteries used to study atherosclerosis is surprisingly complex. The key issue is that changes in mass, here mainly intimal mass or atherosclerotic plaque, correlate poorly with loss of lumen caliber. An analogy to remodeling of microvessels begs the issue of mechanism.
Recent Studies:
To explore this, we have focused on two issues: cell death and intramural coagulation. It is likely that cell death, along with tissue factor, promotes coagulation and, in previously injured vessels, fibrin forms in the wall after a repeat injury. In vitro, fibrin promotes smooth muscle gel contraction mediated by an as yet unidentified beta 1 integrin. In vivo, inhibition of coagulation not only prevents vascular narrowing after a reinjury, but may even result in dilation.
Hypothesis:
We suggest that injury responses, that is, classical wound contracture mechanisms, can be explained as potential pathways for pathologic vascular remodeling.